Medroxyprogesterone acetate [Depo Provera] injections. Development of striae.

Treatment of sex offenders with Depo-Provera.

Medroxyprogesterone acetate (MPA) is capable of reducing male testosterone blood levels with a corresponding reduction in sexual interest and activity. An attempt to evaluate its effectiveness with court committed sexual offenders was made with eight subjects each serving as his own control by alternating Depo-Provera injections for 16 weeks with saline injections for a corresponding 16 weeks. ...

Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss.

Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer.

OBJECTIVE To determine whether use of the injectable contraceptive depot medroxyprogesterone acetate (Depo-Provera) affects the risk of breast cancer in women. DESIGN A population based case-control study. SETTING Nationwide community study. SUBJECTS 891 Women aged 25-54 with newly diagnosed breast cancer were compared with 1864 women selected at random from the electoral rolls. INTERVE...

Comparative evaluation of two once-a-month contraceptive injections.

Two once-a-month preparations cyclo provera (Depo-medroxy Progesterone Acetate 25 mg and Estradiol Cypionate 5 mg) and HRP-102 (Norethisterone enanthate 50 mg and Estradiol Valerate 5 mg) were tried in two groups of women by random allocation, and their effectiveness, complaints and reasons for discontinuation were studied. A total of 206 women were admitted (104 on cyclo provera and 102 on HRP...

Depot medroxyprogesterone injectable contraception at the University of Uyo Teaching Hospital, Uyo.

BACKGROUND Depot medroxyprogesterone acetate is the most studied injectable contraceptive and also one of the most effective methods of contraception currently available. It is reversible, its use is independent of intercourse, and can be provided by trained non-medical staff making it particularly suitable for use in developing countries. The aim of this study is to determine the socio-demogra...